Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
80,62 USD | +0,67% |
|
-1,93% | +5,94% |
Samenstelling van de Invesco Dynamic Pharmaceuticals ETF - USD
Toevoegen aan een lijst 0 geselecteerde |
Koers
|
Verschil (%)
|
Varia. 5d.
|
Vaira. 1 jan.
|
Gewicht
| |
---|---|---|---|---|---|---|
4,53 USD | +3,90% | +6,84% | +114,69% | 7.25% | ||
126,4 USD | +0,48% | +2,14% | +15,99% | 6.19% | ||
914,6 USD | +1,83% | +1,02% | +56,89% | 5.84% | ||
310,9 USD | +0,48% | -0,50% | +7,94% | 5.73% | ||
1.034 USD | +0,99% | -1,60% | +17,75% | 5.61% | ||
146,5 USD | +0,54% | +0,22% | -6,55% | 5.57% | ||
104 USD | +1,65% | +0,11% | -5,50% | 5.54% | ||
28,05 USD | +1,26% | +0,25% | -2,57% | 5.54% | ||
167,2 USD | +2,08% | -2,49% | +7,92% | 5.46% | ||
61,44 USD | +1,02% | -3,52% | +11,43% | 4.18% | ||
314,6 USD | +1,13% | -1,25% | +43,05% | 4.08% | ||
26,03 USD | +0,08% | -2,69% | -10,06% | 4.00% | ||
68,32 USD | +1,49% | -0,77% | +11,60% | 3.83% | ||
30,08 USD | -1,38% | -7,42% | -7,39% | 3.77% | ||
25,44 USD | -2,86% | -0,93% | -20,94% | 3.69% | ||
84,37 USD | +2,02% | +0,13% | +18,13% | 3.64% | ||
16,36 USD | +0,18% | -0,24% | +2,00% | 3.61% | ||
225,6 USD | +0,46% | -2,66% | -12,80% | 3.56% | ||
66,69 USD | +0,15% | -2,80% | -17,68% | 3.39% | ||
21,06 USD | -2,77% | -26,39% | -37,58% | 3.29% | ||
101,3 USD | -2,18% | -5,12% | -17,67% | 3.23% | ||
37,75 USD | -2,10% | -5,62% | -38,97% | 2.93% | ||
Beschrijving
ISIN-code | US46137V6627 |
---|---|
Totalekostenratio (TER) | 0.56% |
Activaklassen | Actions |
Sector | |
Grootte | |
Valuta | |
Beheerder | |
Onderliggende waarde | Dynamic Pharmaceutical Intellidex Total Return Index - USD |
Kenmerken
Dividendbeleid | Distribution |
---|---|
Methode van replicatie | Physique |
Rechtsgebied | |
Fondsstructuur | |
Replicatiemodel | |
Aanmaakdatum |
23-06-2005
|
Geografisch zwaartepunt |
Veranderingen in de stand van zaken ( 31-05-2024 )
Volume (EUR) | 247 M€ |
---|---|
Volume 1 maand | 250 M€ |
AuM 3 months | 258 M€ |
AuM 6 months | 231 M€ |
AuM 12 months | 273 M€ |